NSGC 2023  Visit Us At Booth #209

NSGC 2023 


Contact an Author

Scientific Posters

Poster # TBD

Wednesday, October 18, 2023 5:30 - 7:00pm

. Always Better When We’re Together: A novel, collaborative multi-stakeholder coalition enhances national guidelines for hereditary cancer testing and detection.

Poster # TBD

Wednesday, October 18, 2023 5:00 - 6:30pm

Heather Fecteau, Haley Keller, Shannon Kiernan. If we build it patients will come: A healthcare system's approach to improve identification of at-risk individuals, increase genetic counseling referrals, and build patient management using a digital tool and EMR.

Poster # TBD

Thursday, October 19, 2023 5:30 - 7:00pm

Meghan Towne, Jessica Grzybowski, Jessica Gage, Jesus Ramirez Castano, Heather Zimmermann. Splicing up the Diagnosis: Using Targeted RNA Studies to Reclassify Exome Sequencing Variants.

Poster # TBD

Thursday, October 19, 2023 4:30 - 6:30pm

Haley Keller, Sarah Siddiqui, Heather Fecteau, Carrie Horton, Robert Pilarski, Devon Thrush, Lukas Lyon, Shannon Kieran. Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE programTM accurately identifies high risk individuals.

Oral Presentations

Session # TBD

Wednesday, October 18, 2023 2:00 - 2:15pm

Andrew Giles. Addressing equity in exome sequencing: Proactive reanalysis helps to reduce racial, ethnic, and ancestral disparities

Session # TBD

Wednesday, October 18, 2023 3:15 - 3:30pm

Jenny Geurts, Med College of WI. Identification of High-Risk Hereditary Cancer Syndrome Patients in a Primary Care Cohort Using a Patient Facing Risk Stratification Tool

Session # TBD

Thursday, October 19, 2023 11:00 - 12:30pm

Marcy Richardson, PhD; Tuya Pal (Vanderbilt), Erin Mundt (Myriad), Matthew Lebo (LMMM), Yeni Rodriguez Sanabria. Not All Actionable Variants in BRCA1 and BRCA2 Are Created Equal: Challenges of Classifying and Interpreting Reduced-Penetrance Variants

Session # TBD

Friday, October 20, 2023 7:45 - 8:30am

Meagan Farmer, MS, MBA, LCGC; Meghan Towne, MS, CGC; LGC Kelly Minks, MS, CGC. Reassessed and Revealed: Patient and Genetic Counselor Experience with Proactive Reanalysis

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.


Get in Touch With Us
While You are Here

Set up a Meeting

Search Results

Start your search...